International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.08 and traded as high as $0.12. International Stem Cell shares last traded at $0.12, with a volume of 5,682 shares.
International Stem Cell Stock Performance
The business has a 50-day simple moving average of $0.09 and a two-hundred day simple moving average of $0.08. The stock has a market cap of $960,000.00, a price-to-earnings ratio of -1.50 and a beta of 0.21.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- Investing In Automotive Stocks
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Options Trading – Understanding Strike Price
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
